🔗 Share this article

The Nobel Prize in medical science was awarded for transformative findings that clarify how the body's defense network targets harmful pathogens while protecting the healthy tissues.

Three esteemed researchers—from Japan Shimon Sakaguchi and US scientists Dr. Brunkow and Fred Ramsdell—received this honor.

The work identified unique "sentinels" within the defense system that eliminate rogue defense cells capable of harming the organism.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and malignancies.

The winners will share a monetary award worth 11m Swedish kronor.

Decisive Findings

"The work has been essential for understanding how the body's defenses functions and the reason we do not all develop serious self-attack conditions," stated the chair of the award panel.

The team's studies address a fundamental question: In what way does the defense system protect us from numerous infections while keeping our own tissues intact?

The immune system uses white blood cells that search for indicators of disease, including pathogens and germs it has never encountered.

These cells employ detectors—known as recognition units—that are generated randomly in countless variations.

This provides the immune system the ability to combat a broad range of threats, but the unpredictability of the mechanism inevitably produces immune cells that can target the host.

Protectors of the Immune System

Researchers previously understood that some of these harmful defense cells were destroyed in the thymus—the site where immune cells mature.

This year's award honors the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the system to disarm any immune cells that assault the healthy cells.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel stated, "These findings have established a novel area of investigation and spurred the development of new treatments, for instance for cancer and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from attacking the tumor, so research are aimed at reducing their quantity.

For self-attack disorders, experiments are exploring increasing regulatory T-cells so the organism is not under attack. A comparable approach could also be effective in reducing the risks of transplanted organ failure.

Pioneering Studies

Professor Sakaguchi, from a Japanese institution, conducted tests on mice that had their thymus removed, causing self-attack conditions.

He showed that introducing immune cells from other mice could prevent the illness—implying there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were studying an genetic autoimmune disease in rodents and people that resulted in the discovery of a genetic factor vital for how regulatory T-cells operate.

"The pioneering research has uncovered how the immune system is controlled by T-reg cells, stopping it from mistakenly attacking the healthy cells," commented a leading physiology expert.

"The work is a striking illustration of how fundamental biological study can have broad consequences for human health."